5AM Solutions Announces Release of Updated CONNECT Gateway for the…
In partnership with CGI, firm releases open-source gateway.
(PRWeb April 23, 2012)
Read the full story at http://www.prweb.com/releases/2012/4/prweb9421401.htm
In partnership with CGI, firm releases open-source gateway.
(PRWeb April 23, 2012)
Read the full story at http://www.prweb.com/releases/2012/4/prweb9421401.htm
These features complement DrugPatentWatch’s existing rich feature-set.
The DrugPatentWatch database provides comprehensive information on FDA-approved pharmaceutical drugs, their regulatory status and patent expirations. Complete details are provided for all FDA-approved small molecule drugs, including patent maintenance lapses, paragraph IV challenges, and tentative approvals; annual sales are available for top-selling drugs; and, advanced search and data export capabilities enhance the intuitive user-friendly design.
DrugPatentWatch also provides full-text patent download and search query export.
To preview these features, visit the site tour at http://www.drugpatentwatch.com/tour/ or the Ultimate Plan preview at http://www.drugpatentwatch.com/ultimate/preview/
Drug Safety Executive Councilâ„¢ to host industry panel discussion on the role of metabolomics in adverse event prediction
(PRWeb April 23, 2012)
Read the full story at http://www.prweb.com/releases/DSECmetabolomics/04/prweb9429756.htm
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.

Recent Comments